Low-grade Serous Ovarian Carcinoma

• CLINICAL_TRIALS research · 2026-03-05
  Clinical Trial Update: Fulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous Carcinoma [Phase 2]

  A Phase 2 trial evaluating the combination of fulvestrant and abemaciclib in women with advanced low-grade serous ovarian carcinoma. The stu…

• CLINICAL_TRIALS research · 2026-02-23
  Clinical Trial Update: Nab-Sirolimus and Endocrine Therapy in Recurrent Low Grade Serous Ovarian Cancer (NARETO) [Phase 2]

  Phase 2 clinical trial evaluating nab-sirolimus with endocrine therapy for recurrent low-grade serous ovarian carcinoma. The study is curren…

• CLINICAL_TRIALS trial_result · 2025-12-23
  Clinical Trial Update: Ribociclib and Letrozole Treatment in Ovarian Cancer [Phase 2]

  Phase 2 trial results for ribociclib in combination with letrozole in low-grade serous ovarian carcinoma have been posted.

• CLINICAL_TRIALS research · 2025-09-29
  Clinical Trial Update: MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO) [Phase 3]

  Phase 3 trial MATAO is evaluating maintenance therapy with an aromatase inhibitor in epithelial ovarian cancers; the study is currently recr…

• CLINICAL_TRIALS research · 2025-03-19
  Clinical Trial Update: Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer [Phase 2]

  Phase 2 trial of abemaciclib in combination with letrozole for estrogen receptor-positive rare ovarian cancers. Recruitment is currently ong…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2020-09-29
  Clinical Trial Update: Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer [Phase 2, Phase 3]

  Clinical trial update on trametinib for recurrent or progressive low-grade ovarian cancer and peritoneal serous cancers (Phase 2/Phase 3) wi…